Nobel Laureate’s licensing spat underscores the importance of patent support in universities
Lack of IP funds and staff at Kyoto University may have left immunotherapy pioneer Tasuku Honjo with a poor deal in agreement with Ono Pharmaceutical.
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the IAM experts.